Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population.
Cayla G, Lapostolle F, Ecollan P, Stibbe O, Benezet JF, Henry P, Hammett CJ, Lassen JF, Storey RF, Ten Berg JM, Hamm CW, Van't Hof AW, Montalescot G; ACTION study group. Cayla G, et al. Among authors: lassen jf. Int J Cardiol. 2017 Oct 1;244:49-53. doi: 10.1016/j.ijcard.2017.06.009. Epub 2017 Jun 9. Int J Cardiol. 2017. PMID: 28622941 Clinical Trial.
Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention.
Terkelsen CJ, Lassen JF, Nørgaard BL, Gerdes JC, Poulsen SH, Bendix K, Ankersen JP, Gøtzsche LB, Rømer FK, Nielsen TT, Andersen HR. Terkelsen CJ, et al. Among authors: lassen jf. Eur Heart J. 2005 Apr;26(8):770-7. doi: 10.1093/eurheartj/ehi100. Epub 2005 Jan 31. Eur Heart J. 2005. PMID: 15684279
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Thuesen L. Kelbaek H, et al. Among authors: lassen jf. J Am Coll Cardiol. 2008 Mar 4;51(9):899-905. doi: 10.1016/j.jacc.2007.10.047. J Am Coll Cardiol. 2008. PMID: 18308157 Free article. Clinical Trial.
Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
Maeng M, Jensen LO, Kaltoft A, Hansen HH, Bøttcher M, Lassen JF, Thayssen P, Krusell LR, Rasmussen K, Pedersen L, Sørensen HT, Johnsen SP, Thuesen L. Maeng M, et al. Among authors: lassen jf. Am J Cardiol. 2008 Jul 15;102(2):165-72. doi: 10.1016/j.amjcard.2008.03.034. Epub 2008 May 28. Am J Cardiol. 2008. PMID: 18602515
Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration.
Terkelsen CJ, Oxvig C, Nørgaard BL, Glerup S, Poulsen TS, Lassen JF, Møller HJ, Thuesen L, Falk E, Nielsen TT, Andersen HR. Terkelsen CJ, et al. Among authors: lassen jf. Am J Cardiol. 2009 Jan 1;103(1):29-35. doi: 10.1016/j.amjcard.2008.08.027. Epub 2008 Oct 9. Am J Cardiol. 2009. PMID: 19101225
Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial.
Kaltoft A, Nielsen SS, Terkelsen CJ, Bøttcher M, Lassen JF, Krusell LR, Kristensen SD, Ravkilde J, Kelbaek H, Bøtker HE, Christiansen EH, Rehling M, Thuesen L. Kaltoft A, et al. Among authors: lassen jf. J Nucl Cardiol. 2009 Sep-Oct;16(5):784-91. doi: 10.1007/s12350-009-9105-x. Epub 2009 Jun 12. J Nucl Cardiol. 2009. PMID: 19521742 Clinical Trial.
Left ventricular contractile function after distal protection in primary percutaneous coronary intervention: results from the Drug Elution and Distal Protection in ST-Elevation Myocardial Infarction trial.
Kofoed KF, Kelbæk H, Thuesen L, Poulsen SH, Hassager C, Andersen NH, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Krusell LR, Terkelsen CJ, Køber L. Kofoed KF, et al. Among authors: lassen jf. Int J Cardiol. 2011 Feb 3;146(3):395-8. doi: 10.1016/j.ijcard.2009.07.020. Epub 2009 Aug 22. Int J Cardiol. 2011. PMID: 19700209 Clinical Trial.
Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial.
Kaltoft A, Kelbaek H, Kløvgaard L, Terkelsen CJ, Clemmensen P, Helqvist S, Lassen JF, Thuesen L. Kaltoft A, et al. Among authors: lassen jf. J Am Coll Cardiol. 2010 Mar 2;55(9):867-71. doi: 10.1016/j.jacc.2009.09.052. J Am Coll Cardiol. 2010. PMID: 20185036 Free article. Clinical Trial.
347 results